Carbon-Ion Radiotherapy Plus Camrelizumab for Locally Recurrent Nasopharyngeal Carcinoma

Clinical trial NCT04143984 · UNKNOWN

Trial details

NCT number: NCT04143984
Sponsor: Shanghai Proton and Heavy Ion Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma

Start date: 2021-01-19
Primary completion: 2025-12-20
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.